Alnylam Pharmaceuticals shares owned by Van Eck Associates Corp.
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Van Eck Associates Corp.
from 13F filings
Historical chart of Van Eck Associates Corp. investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Van Eck Associates Corp. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Van Eck Associates Corp.
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $17M | 57k | 295.08 |
| 2024-06-30 | $15M | 61k | 242.83 |
| 2024-03-31 | $8.6M | 58k | 149.27 |
| 2023-12-31 | $12M | 61k | 191.53 |
| 2023-09-30 | $13M | 71k | 177.28 |
| 2023-06-30 | $15M | 78k | 190.28 |
| 2023-03-31 | $16M | 81k | 200.40 |
| 2022-12-31 | $22M | 92k | 238.02 |
| 2022-09-30 | $14M | 70k | 200.57 |
| 2022-06-30 | $16M | 109k | 145.85 |
| 2022-03-31 | $16M | 100k | 163.29 |
| 2021-12-31 | $17M | 99k | 169.58 |
| 2021-09-30 | $18M | 93k | 188.81 |
| 2021-06-30 | $20M | 121k | 169.52 |
| 2021-03-31 | $14M | 100k | 141.19 |
| 2020-12-31 | $14M | 105k | 129.97 |
| 2020-09-30 | $13M | 86k | 145.61 |
| 2020-06-30 | $16M | 111k | 148.11 |
| 2020-03-31 | $9.5M | 87k | 108.85 |
| 2019-12-31 | $13M | 115k | 115.17 |
| 2019-09-30 | $8.9M | 111k | 80.42 |
| 2019-06-30 | $7.6M | 104k | 72.56 |
| 2019-03-31 | $12M | 125k | 93.45 |
| 2018-12-31 | $8.5M | 116k | 72.91 |
| 2018-09-30 | $9.8M | 111k | 87.52 |
| 2018-06-30 | $7.7M | 78k | 98.48 |
| 2018-03-31 | $8.0M | 67k | 119.10 |
| 2017-12-31 | $11M | 87k | 127.05 |
| 2017-09-30 | $18M | 155k | 117.49 |
| 2017-06-30 | $10M | 128k | 79.76 |
| 2017-03-31 | $5.3M | 103k | 51.25 |
| 2016-12-31 | $4.7M | 127k | 37.44 |
| 2016-09-30 | $8.7M | 129k | 67.78 |
| 2016-06-30 | $8.6M | 155k | 55.49 |
| 2016-03-31 | $11M | 172k | 62.77 |
| 2015-12-31 | $18M | 194k | 94.14 |
| 2015-09-30 | $12M | 151k | 80.36 |
| 2015-06-30 | $25M | 206k | 119.87 |
| 2015-03-31 | $20M | 187k | 104.42 |